Yukihiro Iso

688 total citations
56 papers, 399 citations indexed

About

Yukihiro Iso is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Yukihiro Iso has authored 56 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 28 papers in Oncology and 21 papers in Hepatology. Recurrent topics in Yukihiro Iso's work include Pancreatic and Hepatic Oncology Research (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Yukihiro Iso is often cited by papers focused on Pancreatic and Hepatic Oncology Research (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Yukihiro Iso collaborates with scholars based in Japan and Greece. Yukihiro Iso's co-authors include Keiichi Kubota, Tokihiko Sawada, Mitsugi Shimoda, Junji Kita, Taku Aoki, Kyu Rokkaku, Masato Kato, Takayuki Shimizu, Shozo Mori and Takayuki Shiraki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Transplantation.

In The Last Decade

Yukihiro Iso

51 papers receiving 384 citations

Peers

Yukihiro Iso
Bin Qiu China
Yukihiro Iso
Citations per year, relative to Yukihiro Iso Yukihiro Iso (= 1×) peers Bin Qiu

Countries citing papers authored by Yukihiro Iso

Since Specialization
Citations

This map shows the geographic impact of Yukihiro Iso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukihiro Iso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukihiro Iso more than expected).

Fields of papers citing papers by Yukihiro Iso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukihiro Iso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukihiro Iso. The network helps show where Yukihiro Iso may publish in the future.

Co-authorship network of co-authors of Yukihiro Iso

This figure shows the co-authorship network connecting the top 25 collaborators of Yukihiro Iso. A scholar is included among the top collaborators of Yukihiro Iso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukihiro Iso. Yukihiro Iso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shiraki, Takayuki, Takayuki Shimizu, Kyung Hwa Park, et al.. (2024). Proposal of an integrated staging system using albumin-bilirubin grade and serum alpha-fetoprotein values for predicting postoperative prognosis of recurrent hepatocellular carcinoma. European Journal of Surgical Oncology. 50(6). 108356–108356. 1 indexed citations
2.
Shimizu, Takayuki, Norisuke Shibuya, Hiroyuki Hachiya, et al.. (2023). N2 Lymph Node Metastasis Is a Useful Predictor of Recurrence in Patients With Stage III Rectal Cancer Undergoing Adjuvant Chemotherapy Using Tegafur–uracil/leucovorin. Anticancer Research. 43(5). 2219–2225.
4.
Shimizu, Takayuki, Mitsuru Ishizuka, Norisuke Shibuya, et al.. (2022). The preoperative pan-immune-inflammation value is a novel prognostic predictor for with stage I–III colorectal cancer patients undergoing surgery. Surgery Today. 52(8). 1160–1169. 26 indexed citations
5.
Mori, Shozo, Taku Aoki, Takayuki Shimizu, et al.. (2021). Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology. 88(1). 109–120. 2 indexed citations
6.
Mori, Shozo, Taku Aoki, Takayuki Shimizu, et al.. (2021). Efficacy of Adjuvant Chemotherapy According to the Pathological Response to Neoadjuvant Chemotherapy Among Patients With Pancreatic Ductal Adenocarcinoma. Anticancer Research. 41(3). 1629–1639. 5 indexed citations
7.
Mori, Shozo, Taku Aoki, Takayuki Shiraki, et al.. (2021). Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer. Anticancer Research. 41(10). 5231–5240.
8.
Mori, Shozo, Taku Aoki, Takayuki Shimizu, et al.. (2021). Predictors of Poor Pathological Response to Neoadjuvant Gemcitabine Plus S-1 Chemotherapy in Patients With Pancreatic Ductal Adenocarcinoma. Pancreas. 50(5). 744–750. 2 indexed citations
9.
Shimizu, Takayuki, Mitsuru Ishizuka, Takayuki Shiraki, et al.. (2020). The clinical influence of the preoperative lymphocyte‐to‐monocyte ratio on the postoperative outcome of patients with early‐stage gastrointestinal cancer. Annals of Gastroenterological Surgery. 4(5). 580–590. 5 indexed citations
10.
Kubota, Keiichi, Takayuki Shimizu, Kyung Hwa Park, et al.. (2020). Features of Hepatocellular Carcinoma With Micro Hepatic Vein Invasion and their Correlation With Hepatitis B and C Virus. Anticancer Research. 40(7). 3983–3990. 1 indexed citations
11.
Mori, Shozo, Taku Aoki, Takayuki Shimizu, et al.. (2020). The ABO Blood Group Impacts the Survival of Patients Undergoing Pancreatoduodenectomy for Biliary Tract Cancer. In Vivo. 34(4). 1893–1900. 1 indexed citations
12.
Shimizu, Takayuki, Mitsuru Ishizuka, Kyung Hwa Park, et al.. (2019). Preoperative lymphocyte‐to‐monocyte ratio is useful for stratifying the prognosis of hepatocellular carcinoma patients with a low Cancer of the Liver Italian Program score undergoing curative resection. Annals of Gastroenterological Surgery. 3(3). 325–335. 11 indexed citations
13.
Shimizu, Takayuki, Keiichi Kubota, Takayuki Shiraki, et al.. (2019). A technique for taping inferior vena cava caudal to the duodenum: duodenal penetration by IVC filter strut after retroperitoneal lymph node dissection—usefulness of the mesenteric approach. SHILAP Revista de lepidopterología. 5(1). 69–69. 1 indexed citations
14.
Shimizu, Takayuki, Taku Aoki, Shozo Mori, et al.. (2018). Tumor DNA-dependent protein kinase catalytic subunit expression is associated with hepatitis B surface antigen status and tumor progression in patients with hepatocellular carcinoma. Scientific Reports. 8(1). 15019–15019. 3 indexed citations
15.
Shimizu, Takayuki, Mitsuru Ishizuka, Takayuki Shiraki, et al.. (2018). Preoperative lymphocyte-to-monocyte ratio is useful for stratifying the prognosis of HCC patients with low CLIP scores. HPB. 20. S371–S372. 2 indexed citations
16.
Iso, Yukihiro & Keiichi Kubota. (2013). Intragastric Stapled Pancreatic Pseudocystgastrostomy Under Endoscopic Guidance. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 23(3). 330–333. 4 indexed citations
17.
Iwasaki, Yoshimi, Keiichi Kubota, Junji Kita, et al.. (2012). Single-stage intraoperative transhepatic biliary stenting in patients with unresectable hepatobiliary pancreatic tumors. Surgical Endoscopy. 27(2). 505–513. 1 indexed citations
18.
Iwasaki, Yoshimi, Tokihiko Sawada, Shozo Mori, et al.. (2009). Estimating glomerular filtration rate preoperatively for patients undergoing hepatectomy. World Journal of Gastroenterology. 15(18). 2252–2252. 3 indexed citations
19.
Iso, Yukihiro, Tokihiko Sawada, Kyu Rokkaku, Mitsugi Shimoda, & Keiichi Kubota. (2008). Ball-valve gastric tumor associated with anomalous junction of the pancreatico-biliary ductal system and a right-sided round ligament: Report of a case. Surgery Today. 38(5). 458–462. 7 indexed citations
20.
Iso, Yukihiro, et al.. (2005). Loss of E-cadherin mRNA and gain of osteopontin mRNA are useful markers for detecting early recurrence of HCV-related hepatocellular carcinoma. Journal of Surgical Oncology. 92(4). 304–311. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026